Missing/wrong data?
Log in to edit
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
scientific article
Author/s
author: Svenja Nölting, Franziska Briest, Markus Möbs, Britta Siegmund, Michael Lauseker, Carsten Grötzinger, Ashley Grossman
Work details
Publication date
August 11, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.